Introduction
============

Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that is caused by a CAG repeat expansion in the *HTT* gene ([@B32]). This repeat expansion leads to disrupted signaling in cortico-striatal circuits, followed by a loss of projection neurons in the striatum ([@B46]). The neuronal loss and disrupted communication within the brain lead to the characteristic traits of the disease: progressive motor dysfunction, cognitive decline, and behavioral deterioration ([@B71]; [@B52]). Given that symptomology extends beyond basic motor dysfunction into mood and cognition, the cerebral cortex may be implicated in the pathology of HD. In fact, postmortem studies have suggested that neuronal losses are prevalent in the cortex ([@B23]; [@B54]; [@B25]; [@B34]) which warrants *in vivo* investigations in patients.

Since HD is progressive, *in vivo* imaging methods are invaluable for identifying disturbances in brain structure or function over the course of the disease. MRI specifically has shown alterations in the brains of HD patients. These findings have primarily been structural in nature, with decreases in volume reported in the striatum, thalamus, cortical GM, and major subcortical WM tracts ([@B3]; [@B67]; [@B48]; [@B15]; [@B62], [@B64], [@B63]; [@B39]; [@B60]). Previous reports of cortical thinning in HD suggest that thinning begins in motor and visual regions of the cortex and spreads to nearby cortices with HD advancement ([@B49], [@B50]; [@B62]). In terms of cerebral tissue composition, MRI has revealed increases in iron levels in the striatum in HD ([@B4], [@B5]) and most recently, diffusion MRI and quantitative magnetization imaging have suggested a breakdown of myelin in deep WM tracts in HD ([@B6]). Additionally, diffusion tensor imaging (DTI) and functional MRI (fMRI) have been used to display changes in the HD brain. DTI has highlighted that microstructural changes in WM increase with HD progression ([@B51]; [@B72]), that WM microstructure scores are correlated with motor measures ([@B12]; [@B43], [@B44]), and that aberrant network connectivity develops in the HD brain ([@B43]). A compensatory mechanism in the presymptomatic HD brain has been revealed with fMRI studies, where several cortical and subcortical areas have shown increased event-related activation ([@B40]; [@B27]). However, it was shown that cortical activation starts to decrease in symptomatic HD patients ([@B11]). Taken together, MRI provides a sensitive tool for investigating the progressive degeneration of the HD brain.

Although the cortical thickness studies suggest cortical involvement in HD, cortical thickness is a broad measure of cortical pathology that is sensitive to a range of microstructural features ([@B75]). This study aimed to investigate HD progression in the cerebral cortex using intracortical T~1~W and T~2~W MR signal intensity as a potential marker of changes in cortical tissue composition. In the brain, T~1~ ([@B61]) and T~2~ ([@B10]) are sensitive to myelin and iron amounts and can be used to measure tissue water content ([@B36]). Previously, the T~1~W/T~2~W ratio has been used to study the relationship between intracortical myelin levels and aging ([@B21]; [@B55]), the trait of openness ([@B73]), performance stability ([@B21]), and error processing ([@B22]). The ratio of T~1~W and T~2~W images has a reduced sensitivity to bias ([@B19]), aiding in removal of much of the bias artifacts arising from a multi-site study, which may obscure subtle disease-related changes. While these ratio maps have been suggested to map myelin across the cortex ([@B19]), they might not be entirely specific to myelin ([@B1]), especially in the presence of iron or cellular density changes that may be present in HD. Thus, in the present study we interpret the ratio image intensity as a general marker of cortical composition changes in HD rather than being specific for myelin changes.

This study utilizes previously collected MRIs from the cross-sectional TRACK-HD study ([@B62]), which contains a large number of well-described subjects that were imaged at high resolution with multiple MR contrasts including the requisite T~1~W and T~2~W for our analysis. The dataset represents disease stages across HD, starting before disease onset to well after the disease has progressed, which permits the characterization of cortical changes with HD advancement. The neuroimaging portion of the TRACK-HD study ([@B62]) was optimized for gray/white matter contrast to investigate gross structural brain changes. In doing so, they previously revealed widespread decreases in thickness and volume of cortical GM in HD brains. Thus, this study examines the utility of mapping intracortical MRI signal using standard clinical T~1~W and T~2~W images to further characterize HD.

Materials and Methods {#s1}
=====================

TRACK-HD imaging and participant recruitment information has been detailed previously ([@B62]). The main points are summarized below.

Participants
------------

Three hundred and sixty six subjects were recruited from four imaging centers. Each center aimed to recruit a sample of 90 subjects with the following composition: 30 controls, 30 participants with premanifest HD, and 30 participants with early HD. There were 366 images made available to us, with the following distribution: 123 controls, 120 premanifest HD, and 123 early HD.

Premanifest subjects were excluded with a burden of pathology score lower than 250, and had a total motor score below 5 using the motor assessment of the United Huntington's Disease Rating Scale (UHDRS). Healthy control subjects were age- and gender-matched to the combined HD and preHD group. To help control for environmental factors, controls were chosen from spouses or partners of preHD subjects, or were gene-negative siblings. This strict selection criterion aids in associating reported changes with HD.

Huntington's disease participants were further subdivided for analysis. Premanifest HD subjects were split based on the median time for the predicted years to diagnosis ([@B28]) into those far from onset (PreHD-A) and closer to onset (PreHD-B). Early HD subjects were split based on their score on a total functional capacity scale (TFC) ([@B57]) into Stage 1 (HD1, TFC 11--13) and Stage 2 (HD2, TFC 7--10).

In total 40 subjects had data that was not technically suitable for analysis: 19 subjects were excluded in primary stages of processing due to inadequate intrasubject image registration and 21 subjects were excluded in the analysis due to low signal-to-noise ratios in the MRIs, or obvious gain differences between the T~1~W and T~2~W images. Subjects were removed if their mean cortical intensity was outside mean ± 1.5× the standard deviation of the entire cohort, which would suggest a gain difference between the T~1~W and T~2~W images. The remaining 326 subjects used in the study are summarized in Table [1](#T1){ref-type="table"}.

###### 

Demographics for the participants used from the baseline TRACK-HD dataset.

                         Controls (*n* = 112)   PreHD          HD                                                          
  ---------------------- ---------------------- -------------- -------------- -------------- -------------- -------------- --------------
  Age (years)            46.1 (10.5)            40.6 (8.7)     39.6 (8.8)     40.1 (8.9)     47.1 (10.2)    50.9 (8.8)     48.6 (9.8)
  Women                  60 (54%)               30 (56%)       29 (57%)       59 (56%)       40 (59%)       19 (46%)       59 (54%)
  Disease-Burden score   N/A                    259.8 (29.0)   335.4 (30.2)   296.6 (48.2)   357.8 (74.5)   397.2 (69.7)   372.7 (75.3)
  **Centers**                                                                                                              
  Site \#1               25                     14             11             25             15             12             27
  Site \#2               29                     14             16             30             19             11             30
  Site \#3               29                     13             15             28             23             4              27
  Site \#4               29                     13             9              21             11             14             25

Disease-burden score = Age × (CAG length -- 35.5). Data values are mean (SD), or number (%).

Imaging
-------

All images were collected on 3T whole body scanners from two vendors (Siemens \[S\] and Phillips \[P\]). T~1~W images were collected using a 3D MPRAGE acquisition with the following parameters: TR = 2200 ms \[S\]/7.7 ms \[P\], TE = 2.2ms \[S\]/3.5 ms \[P\], TI = 900ms \[S\]/950 ms \[P\], FA = 10° \[S\]/8° \[P\], FOV = 28 cm \[S\]/24 cm \[P\], matrix size 256 × 256 \[S\]/224 × 224 \[P\], 208 \[S\]/164\[P\] sagittal slices with 1 mm thickness to cover the entire brain. T~2~W images were acquired (SPACE sequence on Siemens scanners, VISTA on Phillips scanners) with identical field of view, acquisition matrix, slice thickness and the following timing parameters: TR = 3000 ms, TE = 421 ms.

Processing
----------

The aim of the image processing was to accurately segment GM and WM tissue classes in each subject's T~1~W MRI and construct a middle-depth surface through the cortex for visualizing intracortical MRI signals. The middle depth surface of each subject was registered to a template to allow for group comparisons using a ROI analysis (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}).

The software used for image processing was: MATLAB (vR2015a^[1](#fn01){ref-type="fn"}^), Elastix ([@B26]; [@B56]), ITK-SNAP (version 3.4^[2](#fn02){ref-type="fn"}^) ([@B74]), MIPAV v7.4 software^[3](#fn03){ref-type="fn"}^ using the JIST v3.0 ^[4](#fn04){ref-type="fn"}^, TOADS-CRUISE vR3c ^[5](#fn05){ref-type="fn"}^, and CBS High-Res Brain Processing Tools Version v3.0 ^[6](#fn06){ref-type="fn"}^ plug-ins.

First, images were rigidly registered to begin the cortical segmentation. Each subject's T~2~W image was rigidly registered to that subject's T~1~W image using Elastix. The T~1~W image was rigidly registered to the 1 mm ICBM-152 asymmetric template^[7](#fn07){ref-type="fn"}^, and then the 6-parameter affine transform was applied to the T~2~W image such that both images were co-registered in ICBM-152 space.

Cerebral tissue segmentation was performed on the T~1~W image using custom scripts in MATLAB. First a custom written algorithm was applied to perform local intensity normalization to the T~1~W image to aid in segmentation of the pial surface where cortical signal is artificially reduced in some images due to bias in radiofrequency transmit and receive fields (B~1~+ and B~1~-). Briefly, a new image was created by sliding a 3 × 3× 3 window across the original T~1~W image, with the center voxel location in the new image taking on the greatest intensity value in the original image. This image was smoothed using a 10 mm 3D Gaussian kernel creating an intensity field map. The original T~1~W image was divided by this new image, creating an image where intensity is normalized by nearby voxels. This image was used solely for image segmentation and not for subsequent MRI signal analysis, since meaningful changes in intracortical signal are also potentially normalized.

Next the ICBM-152 template was registered to the subject using a b-spline transform, and the transformation was applied to a smoothed brain mask that had been created in ICBM-152 space. The transformed binary mask was multiplied with the normalized T~1~W image to skull strip the image. The resolution in the masked normalized image was doubled in all dimensions, and then the image was sharpened to further increase the intensity gradient at the pial surface. An intensity threshold was applied to the skull stripped image that was derived using an intensity histogram to calculate the threshold to remove CSF. A morphological algorithm to remove small objects was applied to remove dura mater. The new cerebrum mask was first eroded, then dilated to further remove dura mater. Following this, the cerebrum mask was down sampled back to the original image dimensions. One final threshold operation was applied to remove CSF that may have been added in during the dilation operation. This threshold intensity value was the same as was calculated earlier using the intensity histogram. All segmentations were manually inspected and corrected to remove any remaining dura mater or cerebellum using ITK-SNAP. Each subject's group was blinded to the investigator until after the completion of all image processing.

The cerebrum segmentation was used to mask the locally normalized T~1~W created earlier. The masked image was used as the input to the FANTASM algorithm ([@B42]) in MIPAV, which segmented the image into two tissue classes: WM and GM. Following segmentation, labels for each tissue class were split back into left and right hemispheres for subsequent processing. A volume-preserving cortical depth model was used to generate the middle depth intracortical surface ([@B70]). Additionally, the ICBM-152 asymmetric atlas was processed equivalently to each subject, with automatic GM and WM segmentations that were manually inspected for accuracy, and a middle depth surface generated using a volume-preserving model. Each subject's surface was registered to the middle depth surface generated from the ICBM-152 atlas using a multi-scale surface registration approach ([@B66]). Each hemisphere was registered separately to improve speed and accuracy. Surfaces labeled with the T~1~W/T~2~W ratio intensity were created using CBS-Tools.

As B~1~ maps were not collected at time of imaging to correct inhomogeneities, an alternative approach was used to correct image intensities for analysis. This bias correction methodology is utilized in the preprocessing steps of the Human Connectome Project pipeline, and forms from the inverted contrast between the T~1~W and T~2~W images ([@B18]). Bias field maps were thus calculated and applied to each subject's images using FSL tools ([@B59]). Briefly, an initial estimate of the bias field forms from the square root of the product of the T~1~W and T~2~W images. The cortical mask that was generated in earlier processing steps of this study was applied to the bias map estimation and the resulting image was normalized to the mean value of the map, which now only contains values for inside the cerebrum. Smoothing was applied within the cortical mask, using a Gaussian smoothing kernel with a standard deviation of 5 mm. The resulting bias field was applied to both T~1~W and T~2~W images by a division of the image by the bias field. Finally, a corrected ratio image was generated by dividing the corrected T~1~W image by the corrected T~2~W image.

Statistics
----------

Cortical maps were generated using SurfStat^[8](#fn08){ref-type="fn"}^ in MATLAB, where signal intensity values were smoothed along the surface using a 6 mm Gaussian kernel. The Mars Atlas ([@B2]) was used to parcellate the cortex into 82 ROIs for analysis with linear regressions computed using R^[9](#fn09){ref-type="fn"}^.

Signal intensity as a function of age was investigated for each ROI. As *ncvTest* in R reported non-equal error variance in the linear model, weighted regression was instead used for the analysis. The weight used was 1/standard deviation of the signal intensity for each ROI, which in effect applies a lower weighting to images with more artifacts such as noise. The regression equation took the form: *Signal ∼ Age* + *Study_site* + *Disease_group*, where *Study_site* was a factor with four levels corresponding to the location where the scans were taken. This was used to account for differences in bias fields and imaging methods at each site, and was validated by a lower Akaike criterion compared to using the scanner manufacturer. An age term was included because T~1~W/T~2~W signal intensity has been shown to vary with age in humans ([@B21]). Corrections for type-I errors were performed using the Holm--Bonferroni method ([@B31]) on the resulting *p*-values calculated for each *Disease_group*, accounting for 82 ROIs.

Results
=======

T~1~W/T~2~W Ratio Image Signal
------------------------------

The group signal maps calculated on per-vertex basis are displayed in Figure [1](#F1){ref-type="fig"}. This was computed to be the intercept of the regression equation that included Age and Study_site as regressors to the vertex signal from each subject. Following from this, differences from each HD group relative to the control group based on the T~1~W/T~2~W ratio image intensity are presented in Figure [2](#F2){ref-type="fig"} as was conducted using the Mars Atlas cortical parcellation. The regression coefficients are presented for each group to illustrate the difference relative to the control population. This value represents the residual difference in ratio signal after age and study site are regressed out of the data. Though insignificant, there was a trend for a decrease in T~1~W/T~2~W ratio in the medial precentral gyrus and posterior cingulate cortex in the PreHD-A group. In other cortical regions, ratio intensity predominately demonstrated trends for increasing intensity relative to controls. This trend for increasing intracortical T~1~W/T~2~W intensity was similar for groups: PreHD-A, PreHD-B and HD Stage 1. The *p*-value maps (Figure [2](#F2){ref-type="fig"}, middle; listed in Supplementary Table [1](#SM1){ref-type="supplementary-material"}) illustrate the spread of areas with increasing signal from the insula to other brain regions with disease advancement, however, most of these regions were statistically insignificant following multiple comparison correction. In Stage 2, the furthest progression of the disease included in this study, showed trends for increasing ratio signal across the cortex. Significant regions were found in the HD Stage 1 and 2 group relative to controls following multiple comparison correction, and are shown in the right panel of Figure [2](#F2){ref-type="fig"}. The ratio signal increased in a similar pattern bilaterally within the following significant regions: insula, ventrolateral frontal cortex, superior temporal gyrus, medial temporal gyral pole, and cuneus.

![Middle depth T~1~W/T~2~W ratio signal for each study group. The effects of age and imaging site on the ratio signal were regressed out on a per-vertex basis for each subject before calculation of the average.](fnins-12-00805-g001){#F1}

![T~1~W/T~2~W ratio changes in HD. Coefficients from the intracortical signal analysis are mapped onto the cortex (left), illustrating the difference in ratio signal relative to controls with effects of age and imaging site regressed out of the signal. Uncorrected *p*-values generated for each group from the linear models are mapped onto the cortex for each region to visualize trends in changing intracortical signal (middle). Changes in intracortical signal that are significant following multiple comparison correction are found in HD Stage 1 and 2 (right).](fnins-12-00805-g002){#F2}

Discussion
==========

In this study, we used T~1~W/T~2~W ratio images to map changes in cortical composition across HD time points. The increase found in HD could be reflecting increases in myelin and/or iron amounts, as both of these are prominent features of cortical composition that affect the MR signal ([@B16]). A MRI voxel reporting an increase in myelin could be the result of overall increases in myelin sheaths, or an increased density of myelin due to neuronal loss and/or shrinkage. Oligodendrocytes, the myelin producing cells in the central nervous system, are known to double in density in presymptomatic HD gene carriers in the tail of the caudate nucleus, while other cell densities are unchanged ([@B20]). Neuronal densities have been shown to decrease while oligodendrocyte density increases after HD onset in the caudate ([@B35]). While these findings are in subcortical GM, increased glial density been reported in the GM of the cortex with HD onset as well ([@B38]; [@B45]; [@B54]). These histological findings suggest that the signal increase could be reporting both an increase in myelin levels as well as decreases in neuronal densities, resulting in higher myelin proportions.

Additionally, the increase in ratio signal could be reporting increased levels of cortical iron. It has previously been reported that iron loaded in the ferritin protein increases in subcortical GM in HD ([@B4], [@B5]), and found only after HD onset ([@B13]). Ferritin iron has a strong effect on decreasing T~2~W signal, but only a weak effect on increasing T~1~W signal ([@B69]), where both of these changes would lead to an increase in the ratio studied. While there are conflicting MRI reports of cortical iron accumulation ([@B47]) and iron decreases ([@B53]), both studies agree that iron concentrations become further altered the longer the disease progresses, a finding replicated in this current study. As histology work has reported increases in glia in both subcortical and cortical GM, it is likely that the increase in subcortical iron levels could be present in the cortex as well. Disentangling iron and myelin contributions to signal can be difficult, since oligodendrocytes are iron enriched cells ([@B68]), and combined MRI and histology work has shown that there is considerable overlap in iron and myelin distributions in the cortex ([@B61]). However, it has been shown that only in later stages of HD, ferritin accumulates in the microglia of both the cortical and the striatal tissue ([@B58]). Thus the increase in ratio signal could be separate from changes in myelin, and be reporting increased ferritin levels in cortical microglia. This separation is worth further investigation due to iron's role in oxidative stress, metabolism, and iron-dependent enzyme production, which may contribute to symptomology.

Finally, the increased ratio signal could be due to changes in cytoarchitecture of the cortex, such that there is less bulk water content per imaging voxel. Histological studies have shown that neuronal densities decrease in HD ([@B38]; [@B45]; [@B54]). This decrease in neuronal density and increase in glial density could therefore decrease MR visible water as it has been highlighted in the mammalian central nervous system that neurons have a higher water percentage than glial cells ([@B30]). However, [@B14], previously reported that myelin content dominates the cortical signal over the underlying cytoarchitecture, such that it is unlikely that the change in signal in HD is due to changes in cytoarchitecture. To obtain a better understanding regarding the underlying pathology using neuroimaging, more specific MRI contrasts should be used, such as magnetization transfer for investigating myelin ([@B24]), quantitative susceptibility mapping for iron ([@B29]) and diffusion imaging for exploring neurite density ([@B7]).

The regional variations in signal in this study differ from the pattern of cortical pathology in previous reports from cortical thickness studies ([@B49], [@B50]; [@B62]). It was not necessarily expected that these two analysis techniques would present the same results as they are aimed at differing biological mechanisms. Indeed, it has been shown that tissue composition changes in HD independently of gross structural changes ([@B13]). We did, however, see a trend for an early decrease in signal in the motor regions of the medial cortex, which overlaps with early cortical thinning reported in this region ([@B49], [@B50]; [@B62]). Many of the significant regions found in Stage 2 HD overlap with a previous statistical map depicting regions of cortical thinning correlating with verbal fluency scores in HD ([@B50]). Our finding of the ventrolateral frontal cortex being predominately affected in Stage 2 HD may have structural significance given that this area projects to the caudate ([@B9]), a structure that exhibits rapid degeneration in HD. Ventrolateral frontal cortex appears to be involved in working memory and contextual retrieval ([@B37]; [@B8]), which could be considered be among the executive functions HD patients experience deterioration in ([@B71]).

In this study, it was found that the earliest significant region with increased ratio signal following multiple-comparison correction was the insula. Insular atrophy in HD has previously been correlated with executive dysfunction ([@B41]). Microglia activation in the insula has been shown to be associated with neuronal loss in this area early in the disease ([@B65]). Additionally degeneration of the insula, as well as frontal-striatal circuits has been associated with apathy severity scores in HD ([@B33]). Taken together, insular degeneration appears to be linked strongly with disease symptomology, and future work may look to use the MRI signal in the insula to track HD progression and symptom worsening.

A major limitation of this study is that motion may affect the quality of the MRI image. Due to the retrospective nature of the study, we were unable to control for patient motion. As HD is a movement disorder, it is possible that our results could be confounded by increased subject movement correlating with disease progression. However, care was taken with manual inspection of images during the segmentation step to only include images that appeared motion-free. Additionally, previous work in HD supports the time points of our findings, with late onset showing the greatest changes in tissue composition ([@B47]).

An additional limitation is that there remains a residual bias field artifact in the ratio image after division, which could not be analytically corrected without B~1~ maps. Differences in radiofrequency coil geometries between different MRI vendors and sites can mean that the T~1~W and T~2~W images have intensity bias fields that differ between sites. The T~1~W/T~2~W ratio does well at removing much of the receive field bias (B~1~−), but incomplete canceling of transmit bias (B~1~+). While a correction method was applied to aid in removing some of the residual bias ([@B18]), a proper analytical correction with a B~1~ map would be preferred for accuracy. This inter-site difference was also accounted for in the linear model, where a site term was included to account for inter-site differences in signal that arise from bias fields. Additionally, subjects were removed from analysis that exhibited an obvious gain difference in either the T~1~W or T~2~W image, which would scale the resulting ratio image. A T~1~W/T~2~W calibration algorithm was previously proposed which would scale the contrast in each image to muscle and eye intensity ([@B17]). However, the calibration algorithm was deemed inappropriate to apply as changes in skeletal muscular structure have been shown in HD ([@B76]), such that calibrating to muscle in HD may also provide a confounding factor.

Conclusion
==========

In summary, it was found that HD progression induces widespread changes in cortical tissue composition, which was visible in a large number of subjects using standard anatomical images. It would be valuable to explore cortical pathology in HD using MRI methods that are more specific for features of cortical tissue composition, to better determine whether iron, myelin or both are responsible for this change in ratio signal. Additionally, revisiting this study with imaging optimized for intracortical contrast and MRI protocols that account for intensity biases between imaging sites, may provide increased sensitivity for detecting subtle cortical changes earlier in HD with MRI. With increased sensitivity, it would also be valuable to correlate changes in cortical composition with clinical and behavioral variables as well as other MRI metrics such as DTI. Furthermore, optimized imaging for cortical contrast may allow for detecting HD related changes in smaller cohorts. If intracortical signal mapping can track HD through more disease stages, it may have the potential to be used as a biomarker to mark disease progression in clinical trials.
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